Wave Life Sciences
176 hedge funds and large institutions have $903M invested in Wave Life Sciences in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 84 increasing their positions, 39 reducing their positions, and 40 closing their positions.
1,001% more call options, than puts
Call options by funds: $3.37M | Put options by funds: $306K
115% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 39
3.71% more ownership
Funds ownership: 85.6% → 89.31% (+3.7%)
10% less funds holding
Funds holding: 196 → 176 (-20)
15% less capital invested
Capital invested by funds: $1.06B → $903M (-$159M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
43% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 40
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.03M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$5.67M |
| 4 |
SC
Stempoint Capital
New York
|
+$5.35M |
| 5 |
BlackRock
New York
|
+$4.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.1M |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$8.49M |
| 3 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$2.24M |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$1.81M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$1.73M |
WVE Hedge Fund Activity: Q2 2025 in Review
176 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2025, worth a combined $903M — down 15% from $1.06B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of WVE and 23 opened new positions — a net loss of 17 holders — while 39 trimmed existing stakes and 84 added.
The largest buyer was Adage Capital Partners, adding an estimated $16.5M. The largest seller was Fidelity Investments, cutting an estimated $10.1M.
- 176 institutional investors held Wave Life Sciences (WVE) as of Q2 2025, down from 196 in Q1 2025.
- Funds reported $903M of Wave Life Sciences stock for Q2 2025, down 15% quarter-over-quarter.
- 23 funds opened new Wave Life Sciences positions in Q2 2025 and 40 closed out, a net change of -17 holders.
- The largest Wave Life Sciences buyer in Q2 2025 was Adage Capital Partners, an estimated $16.5M added.
- The largest Wave Life Sciences seller in Q2 2025 was Fidelity Investments, an estimated $10.1M sold.
Based on aggregated 13F filings for Q2 2025.